Alaina J Brown1, Megan Johnson Shen2, Diana Urbauer3, Jolyn Taylor4, Patricia A Parker5, Cindy Carmack6, Lauren Prescott4, Elizabeth Kolawole4, Carly Rosemore4, Charlotte Sun4, Lois Ramondetta4, Diane C Bodurka7. 1. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: AJBrown@mdanderson.org. 2. Department of Medicine, Weill Cornell Medicine, New York, NY, USA. 3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 5. Department of Behavioral Science, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. 6. Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 7. Department of Clinical Education, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract
OBJECTIVES: The goals of this study were: (1) to evaluate patients' knowledge regarding advance directives and completion rates of advance directives among gynecologic oncology patients and (2) to examine the association between death anxiety, disease symptom burden, and patient initiation of advance directives. METHODS: 110 gynecologic cancer patients were surveyed regarding their knowledge and completion of advance directives. Patients also completed the MD Anderson Symptom Inventory (MDASI) scale and Templer's Death Anxiety Scale (DAS). Descriptive statistics were utilized to examine characteristics of the sample. Fisher's exact tests and 2-sample t-tests were utilized to examine associations between key variables. RESULTS: Most patients were white (76.4%) and had ovarian (46.4%) or uterine cancer (34.6%). Nearly half (47.0%) had recurrent disease. The majority of patients had heard about advance directives (75%). Only 49% had completed a living will or medical power of attorney. Older patients and those with a higher level of education were more likely to have completed an advance directive (p<0.01). Higher MDASI Interference Score (higher symptom burden) was associated with patients being less likely to have a living will or medical power of attorney (p=0.003). Higher DAS score (increased death anxiety) was associated with patients being less likely to have completed a living will or medical power of attorney (p=0.03). CONCLUSION: Most patients were familiar with advance directives, but less than half had created these documents. Young age, lower level of education, disease-related interference with daily activities, and a higher level of death anxiety were associated with decreased rates of advance directive completion, indicating these may be barriers to advance care planning documentation. Young patients, less educated patients, patients with increased disease symptom burden, and patients with increased death anxiety should be targeted for advance care planning discussions as they may be less likely to engage in advance care planning.
OBJECTIVES: The goals of this study were: (1) to evaluate patients' knowledge regarding advance directives and completion rates of advance directives among gynecologic oncology patients and (2) to examine the association between death anxiety, disease symptom burden, and patient initiation of advance directives. METHODS: 110 gynecologic cancerpatients were surveyed regarding their knowledge and completion of advance directives. Patients also completed the MD Anderson Symptom Inventory (MDASI) scale and Templer's Death Anxiety Scale (DAS). Descriptive statistics were utilized to examine characteristics of the sample. Fisher's exact tests and 2-sample t-tests were utilized to examine associations between key variables. RESULTS: Most patients were white (76.4%) and had ovarian (46.4%) or uterine cancer (34.6%). Nearly half (47.0%) had recurrent disease. The majority of patients had heard about advance directives (75%). Only 49% had completed a living will or medical power of attorney. Older patients and those with a higher level of education were more likely to have completed an advance directive (p<0.01). Higher MDASI Interference Score (higher symptom burden) was associated with patients being less likely to have a living will or medical power of attorney (p=0.003). Higher DAS score (increased death anxiety) was associated with patients being less likely to have completed a living will or medical power of attorney (p=0.03). CONCLUSION: Most patients were familiar with advance directives, but less than half had created these documents. Young age, lower level of education, disease-related interference with daily activities, and a higher level of death anxiety were associated with decreased rates of advance directive completion, indicating these may be barriers to advance care planning documentation. Young patients, less educated patients, patients with increased disease symptom burden, and patients with increased death anxiety should be targeted for advance care planning discussions as they may be less likely to engage in advance care planning.
Authors: Mae Zakhour; Lia LaBrant; B J Rimel; Christine S Walsh; Andrew J Li; Beth Y Karlan; Ilana Cass Journal: Gynecol Oncol Date: 2015-06-03 Impact factor: 5.482
Authors: Karen B Hirschman; Katherine M Abbott; Alexandra L Hanlon; Janet Prvu Bettger; Mary D Naylor Journal: J Am Med Dir Assoc Date: 2011-02-26 Impact factor: 4.669
Authors: Adam D Schickedanz; Dean Schillinger; C Seth Landefeld; Sara J Knight; Brie A Williams; Rebecca L Sudore Journal: J Am Geriatr Soc Date: 2009-01 Impact factor: 5.562
Authors: Lindsay A Dow; Robin K Matsuyama; V Ramakrishnan; Laura Kuhn; Elizabeth B Lamont; Laurel Lyckholm; Thomas J Smith Journal: J Clin Oncol Date: 2009-11-23 Impact factor: 44.544
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Michael G Cohen; Andrew D Althouse; Robert M Arnold; Hailey W Bulls; Douglas B White; Edward Chu; Margaret Q Rosenzweig; Kenneth J Smith; Yael Schenker Journal: Cancer Date: 2021-11-17 Impact factor: 6.860
Authors: Sarah P Huepenbecker; Sophia Lewis; Mark C Valentine; Marguerite L Palisoul; Premal H Thaker; Andrea R Hagemann; Carolyn K McCourt; Katherine C Fuh; Matthew A Powell; David G Mutch; Lindsay M Kuroki Journal: Gynecol Oncol Rep Date: 2022-08-05
Authors: Rachel A Rodenbach; Andrew D Althouse; Yael Schenker; Thomas J Smith; Edward Chu; Douglas B White; Marie Bakitas; Robert M Arnold Journal: J Pain Symptom Manage Date: 2020-09-12 Impact factor: 3.612
Authors: Michael G Cohen; Andrew D Althouse; Robert M Arnold; Hailey W Bulls; Douglas White; Edward Chu; Margaret Rosenzweig; Kenneth Smith; Yael Schenker Journal: JCO Oncol Pract Date: 2020-06-12